"Health Canada has been advised by Mylan Pharmaceuticals that they have been unable to rule out the possibility that Esme-28 was impacted by the same packaging issue involving Freya-28," Canada's regulator said today. "Therefore, as a precaution, Mylan Pharmaceuticals is expanding their recall to include Esme-28."
Last week, Mylan voluntarily recalled Freya-28 birth control pills across Canada after a pharmacy reported a placebo pill was misplaced in one package.
To date, no packaging errors have been identified with Esme-28.
Packages of Esme-28 should have three rows of active pills that are pink and one row of placebo pills in green.
Women who have purchased Esme-28 are advised to:- Use a non-hormonal method of birth control (such as condoms, spermicidal foam or gel).
- Contact your health-care provider for medical advice.
- Return unopened packages to your pharmacist.
- Report any adverse reactions potentially related to Esme-2 to Health Canada.Suggest a correction